APA (7th ed.) Citation

Otto, M., Krebs, J., Welker, P., Holm, R., Thiel, M., Gattinoni, L., . . . Tsagogiorgas, C. (2021). Inhalationally administered semifluorinated alkanes (SFAs) as drug carriers in an experimental model of acute respiratory distress syndrome. Pharmaceutics, 13(3), . https://doi.org/10.3390/pharmaceutics13030431

Chicago Style (17th ed.) Citation

Otto, Matthias, Jörg Krebs, Peter Welker, René Holm, Manfred Thiel, Luciano Gattinoni, Michael Quintel, and Charalambos Tsagogiorgas. "Inhalationally Administered Semifluorinated Alkanes (SFAs) as Drug Carriers in an Experimental Model of Acute Respiratory Distress Syndrome." Pharmaceutics 13, no. 3 (2021). https://doi.org/10.3390/pharmaceutics13030431.

MLA (9th ed.) Citation

Otto, Matthias, et al. "Inhalationally Administered Semifluorinated Alkanes (SFAs) as Drug Carriers in an Experimental Model of Acute Respiratory Distress Syndrome." Pharmaceutics, vol. 13, no. 3, 2021, https://doi.org/10.3390/pharmaceutics13030431.